Given Imaging announced that the U.S. Food and Drug Administration has cleared PillCam COLON — a device that provides a new way to visualize the colon.
The device, an effective colon imaging option, may be used for detection of colon polyps in patients after an incomplete optical colonoscopy — without adequate preparation and an incomplete evaluation of the colon.
PillCam COLON received clearance under the direct de novo classification for devices with low to moderate risk that have no predicate on the market.
Boston Scientific Looks to Expand Chinese Presence
Supply Chain Efficiency Improved With Inventory Management Intervention
The device, an effective colon imaging option, may be used for detection of colon polyps in patients after an incomplete optical colonoscopy — without adequate preparation and an incomplete evaluation of the colon.
PillCam COLON received clearance under the direct de novo classification for devices with low to moderate risk that have no predicate on the market.
More Articles on Supply Chain:
Medline Launches New Products CatalogBoston Scientific Looks to Expand Chinese Presence
Supply Chain Efficiency Improved With Inventory Management Intervention